School of Pharmacy at Queen's University Belfast

School of Pharmacy at Queen's University Belfast The School of Pharmacy at Queen's University Belfast is one of the UK's leading teaching and research

The School of Pharmacy at Queen’s is acknowledged as a leading centre for Pharmacy teaching and research in the UK, focusing on the practice of pharmacy and advancements in the pharmaceutical sciences. Research in the School was returned in REF 2021 as part of the Allied Health Professions, Dentistry, Nursing and Pharmacy Unit of Assessment, which was ranked 4th= in the UK overall, and 2nd in the

UK for Research Power (data from Times Higher Education, 2022)

The School of Pharmacy offers two exceptional degree courses, namely the MPharm (Pharmacy) degree and a BSc in the Pharmaceutical Sciences. Our professional degree has recently been accredited by the UK's governing pharmacy body, The GPhC, for a maximum term, further indicating the excellence offered by our taught undergraduate programmes. More information can be found on our website, at www.qub.ac.uk/pha

31/08/2026

Just one week until QPEC 2026 - Queen's Pharmacy Education Conference at the School of Pharmacy on Monday 7 September 💙

We are pleased to welcome two keynote speakers - Professor Judy Williams, Pro-Vice-Chancellor for Education and Students at Queen's, and Joanne Kissane, Registrar and Chief Officer of the Pharmaceutical Society of Ireland - along with a panel discussion drawing on perspectives from education and practice.

The conference theme is Transforming Pharmacy Education through Innovation, and the day brings together colleagues, researchers and students from institutions across the island of Ireland and beyond. We'll have a wide range of presentations on the programme - short oral papers, snapshot talks and posters - covering experiential learning and placements, simulation, assessment, inclusion and universal design, digital and AI, patient and public involvement, workforce development, and student wellbeing.

The conference app is now live 📱 It carries the full programme, poster board numbers, travel and venue information, and lets you save the sessions you would like to attend to your own schedule. It works offline once you have opened it, which should help in a busy building.

Get the app ➡️ https://qpec.app

Visit the conference web page and register https://go.qub.ac.uk/QPEC26

Congratulations to MPharm students Rebecca Dwyer, Elle Frith and Sophie Watson, who have all recently completed summer p...
31/08/2026

Congratulations to MPharm students Rebecca Dwyer, Elle Frith and Sophie Watson, who have all recently completed summer placements at Alder Hey Children's Hospital.

Rebecca shared: "During my time at Alder Hey Children's Hospital, I had the opportunity to experience a wide range of specialties and learn about the varied roles of specialist pharmacists. We were warmly welcomed by the entire team, who made our learning and ensuring we had the best possible experience a clear priority."

Highlights across the week included cystic fibrosis clinics with multidisciplinary teams, ward rounds on the neonatal intensive care unit reviewing sedation and pain management, oncology and dermatology case discussions, and time with the Child and Adolescent Mental Health Services. The students also completed an audit during the placement.

Sophie added that the experience "really solidified my love for paediatric pharmacy." We're delighted for all three.

We're now over one hundred days into the Ebola outbreak in the Democratic Republic of the Congo, and more than 2,000 peo...
30/08/2026

We're now over one hundred days into the Ebola outbreak in the Democratic Republic of the Congo, and more than 2,000 people have died, with health teams struggling to contain the spread.

It's a sobering reminder of why our Infection and Antimicrobial Resistance research theme matters, and why we train pharmacists prepared to respond to global health threats.

Read The Guardian's explainer here: https://www.theguardian.com/world/video/2026/aug/23/ebola-day-100-why-this-outbreak-could-become-deadliest-in-history-explainer

Find out more about the research work that we do in this area at https://www.qub.ac.uk/schools/SchoolofPharmacy/Research/

Roche is investing $750 million to double the capacity of its Oregon fill-finish site, producing autoinjectors and pre-f...
29/08/2026

Roche is investing $750 million to double the capacity of its Oregon fill-finish site, producing autoinjectors and pre-filled syringes for its biologics pipeline.

Sterile fill-finish and device design are core areas of pharmaceutical manufacturing, and career paths our graduates step into around the world.

More on the story: https://www.pharmaceutical-technology.com/news/roche-750m-oregon-us-injectable-manufacturing-site/

Find out more about how to study with us at http://go.qub.ac.uk/PMYProgrammes

A new peer-reviewed study has found unlabelled toxic chemicals in around 85% of more than 110 personal care products tes...
29/08/2026

A new peer-reviewed study has found unlabelled toxic chemicals in around 85% of more than 110 personal care products tested, including some marketed as "green" or "natural".

It's a clear reminder of why formulation transparency and consumer safety matter, and why pharmaceutical scientists and biotechnologists have a real role to play in understanding what's in the products people use every day, with pharmacists ensuring that patients are fully informed about the products they wish to use, and the risks that are involved.

You can read the full story via The Guardian here: https://www.theguardian.com/us-news/2026/aug/23/personal-care-products-unlabeled-toxic-chemicals

Find out more about how to study with us at http://go.qub.ac.uk/PMYProgrammes

The School of Pharmacy is deeply saddened by the death of Professor David Woolfson, who passed away on 19 August 2026.A ...
27/08/2026

The School of Pharmacy is deeply saddened by the death of Professor David Woolfson, who passed away on 19 August 2026.

A graduate of the School and later Professor of Pharmaceutics, Director of Research and Head of School, David shaped the School over a career spanning more than four decades. His research, including the development of Ametop® and Femring®, together with the partnerships he built and the leadership he brought to the School, helped ensure the future of pharmacy at Queens and establish the School as a world leading centre for pharmaceutical education and research.

"For many of us, David was far more than a colleague. He was a friend, a mentor and a tireless champion of this School. His leadership was direct, pragmatic and decisive, and his influence on the School, on the profession, and on the people around him was immense. He will be remembered with great affection, gratitude and respect." — Professor Gavin Andrews, Head of School

Our thoughts are with David's wife Una and his son Steven at this difficult time.

Moderna and Merck have released new data on their personalised mRNA melanoma vaccine, Intismeran.For us here at the Scho...
27/08/2026

Moderna and Merck have released new data on their personalised mRNA melanoma vaccine, Intismeran.

For us here at the School, this is of immense interest. Personalised cancer vaccines are central to what goes on within our Nanomedicine and Biotherapeutics research theme, and the journey from molecule to clinic is moving faster than ever, something our students and researchers are engaging with directly.

Read more via BioPharma Dive: https://www.biopharmadive.com/news/moderna-merck-intismeran-melanoma-vaccine-stock-reaction/828332/

Find out more about our research at https://www.qub.ac.uk/schools/SchoolofPharmacy/Research/

Irish hospitals are reporting a rise in patients presenting with side effects from Retatrutide, a weight-loss drug that ...
26/08/2026

Irish hospitals are reporting a rise in patients presenting with side effects from Retatrutide, a weight-loss drug that has not yet received regulatory approval.

It's a timely reminder of why approval processes and pharmacist-led medicines advice matter so much. When medicines are sourced outside the regulated supply chain, there are no guarantees around quality, dosing or safety, and it's often pharmacists who see the consequences first.

These are themes we return to throughout our pharmacy programmes, from the pharmacology of new therapies, to the professional judgement pharmacists use every day.

Full story via RTÉ: https://www.rte.ie/news/health/2026/0823/1588400-weight-loss-drug/

Find out more about how to study with us at http://go.qub.ac.uk/PMYProgrammes

Eli Lilly's once-weekly insulin, Onswik, could reduce injections for people with type 2 diabetes by up to 85% if approve...
25/08/2026

Eli Lilly's once-weekly insulin, Onswik, could reduce injections for people with type 2 diabetes by up to 85% if approved for NHS use.

Reformulating an existing therapy to ease the daily burden on patients is exactly the kind of innovation many of our researchers explore here at the School. And if Onswik does reach NHS patients, community and hospital pharmacists will be central to guiding them through the switch from daily to weekly dosing, once again highlighting the crucial role that pharmacy plays in making sure these medical advancements can have maximum effect.

Read more: https://www.pharmaceutical-technology.com/news/eli-lillys-weekly-insulin-jab-onswik-set-for-nhs-use-if-approved/
..and find out more about what we do at www.qub.ac.uk/pha

Address

97 Lisburn Road
Belfast
BT97BL

Website

Alerts

Be the first to know and let us send you an email when School of Pharmacy at Queen's University Belfast posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The University

Send a message to School of Pharmacy at Queen's University Belfast:

Shortcuts

Share